Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jada G Hamilton

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Journal of General Internal Medicine|June 26, 2021
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR StudyLydia E Pace, Nadine Tung, Yeonsoo S Lee, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 VariantsGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> CarriersGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2021
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancerJada G Hamilton, Heather Symecko, Kelsey Spielman, et al.
BMJ Open|April 28, 2018
Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-AnalysisMelissa K Frey, Muhammad Danyal Ahsan, Hannah Bergeron, et al.
Gynecologic Oncology|March 16, 2024
Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptakeMaureen Byrne, Tiffany Y Sia, Christopher Fong, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 12, 2019
Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trialYvonne Bombard, Marc Clausen, Salma Shickh, et al.
BMJ Open|October 10, 2019
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort studyKelly M Morgan, Jada G Hamilton, Heather Symecko, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of General Internal Medicine|June 26, 2021
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR StudyLydia E Pace, Nadine Tung, Yeonsoo S Lee, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 VariantsGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> CarriersGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2021
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancerJada G Hamilton, Heather Symecko, Kelsey Spielman, et al.
BMJ Open|April 28, 2018
Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-AnalysisMelissa K Frey, Muhammad Danyal Ahsan, Hannah Bergeron, et al.
Gynecologic Oncology|March 16, 2024
Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptakeMaureen Byrne, Tiffany Y Sia, Christopher Fong, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 12, 2019
Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trialYvonne Bombard, Marc Clausen, Salma Shickh, et al.
BMJ Open|October 10, 2019
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort studyKelly M Morgan, Jada G Hamilton, Heather Symecko, et al.
Pageof 9